Robots in Your Head - WTF? Learn How Robots Will Transform Retail, Industry and Even Your Own Body
We've all heard how robots will replace jobs as far-reaching as factory QA, baristas and even caretakers. It's only the first inning, and robots will become far more pervasive across industries including heavily regulated ones such as healthcare and the treatment of disease. Come learn what's happening at the edge of industry, retail and even your own body.
Aviad founded Bionaut Labs with the vision of transforming drug development into a predictable process. Today multiple localized health conditions (e.g., cancer tumors) are treated using systemic drug delivery or invasive surgical procedures, resulting in limited efficacy and safety. Existing targeted delivery technologies rely on passive motion in the bloodstream or diffusion in tissue, leaving accurate delivery up to chance. Bionaut Labs aims to change this paradigm, creating a revolutionary treatment modality for a wide range of clinical conditions. The Bionaut vision is part of a medical future where treatment development is no longer ruled by randomness, localized clinical conditions are treated locally and not systemically, where medicine is personalized on the anatomic level and not “one size”, where medical diagnostics are seamless, accurate and continuous rather than invasive, noisy and infrequent.
Aviad was founder and president of PrimeSense, a 3D sensing company for consumer and commercial markets, best known as the technology behind Microsoft's Kinect as well as the facial recognition features of the IPhone X. In 2013, the company was acquired by Apple Inc. Aviad received the World Economic Forum’s Technological Pioneer award in 2013, and has been named by Business Insider Tech one of the most influential Israelis in tech. Among others, he is serving today on the boards of the Weizmann International Board, Yeda Research and Development company and the Schwartz/Reisman Science Education Center.
Erik Schluntz is the CTO and Co-Founder of Cobalt Robotics. He is an accomplished engineer and entrepreneur, having obtained his Masters and Bachelors in Electrical Engineering from Harvard University. Previously, Mr. Schluntz worked for Google[x] on the Smart Contact Lens project, and he was on the SpaceX’s Flight Software Team, where he led testing for an entirely new fuel system and video telemetry systems on the Falcon 9 rocket in 2015.
Jeremy Conrad is the CEO of a new robotics company focused on the future of automation. Previously he was a founding partner at Lemnos, an early stage hardware focused venture fund. Prior to Lemnos Mr. Conrad was an active duty United States Air Force officer working on the Airborne Laser Program. Mr. Conrad received his B.S. in Mechanical Engineering from the Massachusetts Institute of Technology.
Dr. Paolo Pirjanian is the founder/CEO of Embodied inc. a robotics and AI company based in Pasadena, CA. Most recently he was the chief technology officer of iRobot where he lead technology and product innovation leading to a break-through visual indoor mapping and navigation technology which is now powering millions of home robots. Prior to joining iRobot, he was the founder and chief executive officer of Evolution Robotics, Inc. Earlier in his career, he worked as a lecturer, teaching AI at the computer science department at the University of Southern California and as a researcher at the NASA Jet Propulsion Laboratory. Pirjanian has and still is serving as the chairman and board of directors of various technology organization and companies. He has more than 50 issued patents in robotics, AI and related fields.
Kevin joined Upfront Ventures in 2012. Most recently, Kevin was at Boston Consulting Group, where he advised on strategy and operations for technology, healthcare, and industrial goods clients in the US and Asia and conducted due diligence for private equity investors. Previously, Kevin worked at Verisk Health, a healthcare IT startup in Boston, focusing on project management, product development, and consulting for strategic accounts.